Leukoencephalopathies and metabolic diseases

Kolodny EH (1993) Dysmyelinating and demyelinating conditions in infancy. Curr Opin Neurol Neurosurg 6:379–386

De Stefano N, Mortilla M (2007) Proton magnetic resonance spectroscopy in brain metabolic disorders. Clin Neurorad 17:223–229

van der Voorn JP, Pouwels PJ, Hart AA et al (2006) Childhood white matter disorders: quantitative MR imaging and spectroscopy. Radiology 241:510–517

Kruse B, Hanefeld F, Christen HJ et al (1993) Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivo. J Neurol 241:68–74

Provenzale JM, Escolar M, Kurtzberg J (2005) Quantitative analysis of diffusion tensor imaging data in serial assessment of Krabbe disease. Ann N Y Acad Sci 1064:220–229

Sylvain M, Arnold DL, Scriver CR et al (1994) Magnetic resonance spectroscopy in Niemann-Pick disease type C: correlation with diagnosis and clinical response to cholestyramine and lovastatin. Pediatr Neurol 10:228–232

De Stefano N, Balestri P, Dotti MT et al (2001) Severe metabolic abnormalities in the white matter of patients with vacuolating megalencephalic leukoencephalopathy with subcortical cysts. A proton MR spectroscopic imaging study. J Neurol 248:403–409

van der Knaap MS, Barth PG, Gabreels FJ et al (1997) A new leukoencephalopathy with vanishing white matter. Neurology 48:845–855

Tedeschi G, Schiffmann R, Barton NW et al (1995) Proton magnetic resonance spectroscopic imaging in childhood ataxia with diffuse central nervous system hypomyelination. Neurology 45:1526–1532

Grodd W, Krageloh-Mann I, Petersen D et al (1990) In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan’s disease) by proton spectroscopy. Lancet 336:437–438

Rajanayagam V, Grad J, Krivit W et al (1996) Proton MR spectroscopy of childhood adrenoleukodystrophy. AJNR Am J Neuroradiol 17:1013–1024

Dubey P, Fatemi A, Huang H et al (2005) Diffusion tensor-based imaging reveals occult abnormalities in adrenomyeloneuropathy. Ann Neurol 58:758–766

Marino S, De Luca M, Dotti MT et al (2007) Prominent brain axonal damage and functional reorganization in “pure” adrenomyeloneuropathy. Neurology 69:1261–1269

De Stefano N, Narayanan S, Matthews PM et al (2000) Proton MR spectroscopy to assess axonal damage in multiple sclerosis and other white matter disorders. J Neurovirol 6[Suppl 2]:S121–S129

Schulze A (2003) Creatine deficiency syndromes. Mol Cell Biochem 244:143–150

Martin E, Capone A, Schneider J et al (2001) Absence of N-acetylaspartate in the human brain: impact on neurospectroscopy? Ann Neurol 49:518–521